Auditory Rehabilitation With Hearing Aids and Cognition in Alzheimer Patients
The trial, sponsored by University Hospital, Tours, investigates the impact of auditory rehabilitation on cognitive decline in Alzheimer's patients, a growing demographic with significant unmet needs. The market for hearing aids is expanding, particularly among the elderly population, which is increasingly affected by both hearing loss and cognitive disorders. If the trial demonstrates efficacy, it could position hearing aids as a critical component of Alzheimer's care, potentially leading to increased adoption and sales in this segment. Competitive analysis should focus on existing cognitive therapies and hearing aid manufacturers, assessing their market strategies and product offerings. Due diligence should include evaluating regulatory pathways and reimbursement scenarios in France and other European markets.
Indication: Alzheimer's Disease
Modality: medical device
Target: Auditory rehabilitation through hearing aids aimed at improving cognitive functions in Alzheimer's patients with sensorineural hearing loss.
Sponsor: University Hospital, Tours
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 15, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Auditory rehabilitation through hearing aids aimed at improving cognitive functions in Alzheimer's patients with sensorineural hearing loss.
View original source fields
Condition raw: Alzheimer's Disease, Hearing Loss
Condition normalized: Alzheimer's Disease, Hearing Loss
Modality raw: medical device
Modality normalized: medical device
Target raw: Auditory rehabilitation through hearing aids aimed at improving cognitive functions in Alzheimer's patients with sensorineural hearing loss.
Target normalized: Auditory rehabilitation through hearing aids aimed at improving cognitive functions in Alzheimer's patients with sensorineural hearing loss.